Galactosylated Poly(Ethyleneglycol)‐Lithocholic Acid Selectively Kills Hepatoma Cells, While Sparing Normal Liver Cells
- 6 February 2015
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 15 (6) , 777-787
Abstract
Delivering drugs selectively to cancer cells but not to nearby normal cells is a major obstacle in drug therapy. In this study, lithocholic acid (LCA), a potent anti‐cancer drug, is converted to two forms of poly(ethyleneglycol) (PEG) conjugates, viz., PEG‐LCA (PL) and lactobionic acid (LBA) conjugated PEG‐LCA (LPL). The latter form contains a galactose ligand in LBA to target the hepatocytes. Both forms are self‐assembled to form nanoparticle formulation, and they have high potency than LCA to kill HepG2 cancer cells, sparing normal LO2 cells. Besides, LPL has high specificity to mouse liver cells in vivo. Western blot results confirm that the cell death is occurred through apoptosis induced by LPL nanoparticles. In conclusion, the induction of apoptosis and cell death is much more efficient with LPL nanoparticles than LCA molecules.Keywords
This publication has 27 references indexed in Scilit:
- PEGylated nanomedicines: recent progress and remaining concernsExpert Opinion on Drug Delivery, 2013
- Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cellsPeerJ, 2013
- Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsOncotarget, 2011
- A Perspective on Cancer Cell MetastasisScience, 2011
- PEG conjugates in clinical development or use as anticancer agents: An overviewAdvanced Drug Delivery Reviews, 2009
- Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical MucusMolecular Pharmaceutics, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis PathwayPharmacological Reviews, 2002
- Receptor-mediated delivery of foreign genes to hepatocytesAdvanced Drug Delivery Reviews, 1998
- Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosisAdvanced Drug Delivery Reviews, 1994